Candice Maenza received salary support from a National Institutes of Health grant. Robert Sainburg receives funding from the National Institutes of Health, National Institute of Child Health and ...

Stroke survivors often face substantial and long-lasting problems with their arms. Both arms often decline together: When one arm is more severely affected by the stroke, the other becomes more ...

Traditional stroke rehabilitation therapy focuses on restoring strength and movement to the more impaired side of the body, but a new randomized clinical trial has revealed that targeted therapy for ...

Targeted therapy of the ipsilesional, or “good” arm, improved motor function, including control and speed, in chronic stroke survivors with severe paresis. In a small randomized clinical trial ...

(THE CONVERSATION) Stroke survivors often face substantial and long-lasting problems with their arms. Both arms often decline together: When one arm is more severely affected by the stroke, the other ...

The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA stroke prevention trial. The primary goal of the trial is to determine if ...

The National Institutes of Health (NIH) halted a treatment arm of Bayer and Johnson & Johnson’s Xarelto (rivaroxaban) in a phase 3 stroke prevention trial after an independent committee flagged safety ...

HERSHEY, Pa. — Traditional stroke rehabilitation therapy focuses on restoring strength and movement to the more impaired side of the body, but a new randomized clinical trial has revealed that ...